Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C13H16ClNO |
Molecular Weight | 237.725 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CN[C@@]1(CCCCC1=O)C2=CC=CC=C2Cl
InChI
InChIKey=YQEZLKZALYSWHR-ZDUSSCGKSA-N
InChI=1S/C13H16ClNO/c1-15-13(9-5-4-8-12(13)16)10-6-2-3-7-11(10)14/h2-3,6-7,15H,4-5,8-9H2,1H3/t13-/m0/s1
Molecular Formula | C13H16ClNO |
Molecular Weight | 237.725 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Esketamine is an S(+)-enantiomer of ketamine. It is a nonselective, noncompetitive antagonist of N-methyl-D-aspartate (NMDA) receptor. A nasal spray, containing esketamine, was approved in 2019 for the treatment of treatment-resistant depression in adults, in conjunction with an oral antidepressant, and is marketed under tradename SPARAVATO. Esketamine is a schedule III drug product in the USA.
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Oct 21 21:11:39 UTC 2019
by
admin
on
Mon Oct 21 21:11:39 UTC 2019
|
Record UNII |
50LFG02TXD
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ATC |
N01AX14
Created by
admin on Mon Oct 21 21:11:39 UTC 2019 , Edited by admin on Mon Oct 21 21:11:39 UTC 2019
|
||
|
NCI_THESAURUS |
C245
Created by
admin on Mon Oct 21 21:11:39 UTC 2019 , Edited by admin on Mon Oct 21 21:11:39 UTC 2019
|
||
|
WHO-VATC |
QN01AX14
Created by
admin on Mon Oct 21 21:11:39 UTC 2019 , Edited by admin on Mon Oct 21 21:11:39 UTC 2019
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
ESKETAMINE
Created by
admin on Mon Oct 21 21:11:39 UTC 2019 , Edited by admin on Mon Oct 21 21:11:39 UTC 2019
|
PRIMARY | |||
|
7884
Created by
admin on Mon Oct 21 21:11:39 UTC 2019 , Edited by admin on Mon Oct 21 21:11:39 UTC 2019
|
PRIMARY | |||
|
SUB25825
Created by
admin on Mon Oct 21 21:11:39 UTC 2019 , Edited by admin on Mon Oct 21 21:11:39 UTC 2019
|
PRIMARY | |||
|
33643-46-8
Created by
admin on Mon Oct 21 21:11:39 UTC 2019 , Edited by admin on Mon Oct 21 21:11:39 UTC 2019
|
PRIMARY | |||
|
CHEMBL395091
Created by
admin on Mon Oct 21 21:11:39 UTC 2019 , Edited by admin on Mon Oct 21 21:11:39 UTC 2019
|
PRIMARY | |||
|
33643-46-8
Created by
admin on Mon Oct 21 21:11:39 UTC 2019 , Edited by admin on Mon Oct 21 21:11:39 UTC 2019
|
PRIMARY | |||
|
182137
Created by
admin on Mon Oct 21 21:11:39 UTC 2019 , Edited by admin on Mon Oct 21 21:11:39 UTC 2019
|
PRIMARY | |||
|
C81400
Created by
admin on Mon Oct 21 21:11:39 UTC 2019 , Edited by admin on Mon Oct 21 21:11:39 UTC 2019
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT | |||
|
RACEMATE -> ENANTIOMER |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE ACTIVE -> PARENT |
NMDA receptor (rat brain) binding assay
IN-VITRO
Ki
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |